The medication demonstrates substantial efficacy in reducing hemoglobin A1c levels and promoting weight loss, with reductions of up to 21% of body weight observed in clinical trials of patients with obesity without diabetes, and approximately 12-15% in those with type 2 diabetes
"Because GLP-1s are so effective at suppressing appetite, clinical support is vital to ensure individuals are meeting their nutritional needs, particularly around protein intake and activity levels
Some men consider growth hormone secretagogues like sermorelin or ipamorelin alongside metabolic peptides to support lean mass retention
However, its important to note that outcomes are significantly better when semaglutide is combined with lifestyle changes such as improved nutrition and regular physical activity
Individual results vary based on starting weight, dose, nutrition, movement, and adherence